Skip to content Skip to content

Press Releases


Filter Releases
 
INCLINE VILLAGE, Nev., July 29, 2015 /PRNewswire/ -- PDL BioPharma, Inc. (NASDAQ: PDLI) today announced that it has entered into a revenue interest assignment agreement (the "Agreement") in which it has agreed to provide ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) with up to $200 million in revenue interest financing in exchange for royalties on the...
INCLINE VILLAGE, Nev., July 28, 2015 /PRNewswire/ -- PDL BioPharma, Inc. (PDL, or the Company) (NASDAQ: PDLI) today announced that the Company will release its second quarter 2015 financial results for the period ended June 30, 2015, on Wednesday, August 5, 2015, after market close. PDL's management will host a conference call and webcast that day ...
INCLINE VILLAGE, Nev., June 29, 2015 /PRNewswire/ -- PDL BioPharma, Inc. (NASDAQ: PDLI) today announced that it has entered into a credit agreement with CareView Communications, Inc. (OTCQB: CRVW) whereby PDL will provide CareView with up to $40 million of secured debt financing. CareView is an information technology provider to the healthcare indu...
INCLINE VILLAGE, Nev., June 25, 2015 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that John P. McLaughlin, the company's president and chief executive officer, will present at the Nasdaq 32nd Investor Program in London, England.  The fireside chat-style of presentation will be webcast and will occur on Tuesday, June 30, ...
INCLINE VILLAGE, Nev., June 24, 2015 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that the company has appointed Steffen Pietzke, CPA, to the position of controller and chief accounting officer. Mr. Pietzke officially joins the company this week. "Steffen is an excellent addition to PDL and brings over 14 years of...
INCLINE VILLAGE, Nev., June 15, 2015 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that it has paid the June 12, 2015, regular quarterly dividend payment of $0.15 per share to all stockholders owning shares of PDL as of June 5, 2015, the record date. About PDL BioPharmaPDL manages a portfolio of patents and royalt...
INCLINE VILLAGE, Nev., May 27, 2015 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that John P. McLaughlin, the company's president and chief executive officer, will present at the Jefferies 2015 Global Healthcare Conference next week in New York City.  The presentation, which will be webcast, will occur on Wednesday, June...
INCLINE VILLAGE, Nev., May 6, 2015 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today reported financial results for the first quarter ended March 31, 2015. Total revenues for the first quarter of 2015 increased nine percent to $149.7 million from $136.8 million in the first quarter of 2014. Revenues for the quarter ended March ...
INCLINE VILLAGE, Nev., April 29, 2015 /PRNewswire/ -- PDL BioPharma, Inc. (PDL, or the Company) (NASDAQ: PDLI) today announced that the Company will release its first quarter 2015 financial results for the period ended March 31, 2015, on Wednesday, May 6, 2015, after market close. PDL's management will host a conference call and webcast that day at...
INCLINE VILLAGE, Nev., March 12, 2015 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that it has paid the March 12, 2015, regular quarterly dividend payment of $0.15 per share to all stockholders owning shares of PDL as of March 5, 2015, the record date. About PDL BioPharmaPDL manages a portfolio of patents and roy...
INCLINE VILLAGE, Nev., March 4, 2015 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that the adjusted conversion rate for the: 3.75% Convertible Senior Notes due May 1, 2015 (May 2015 Notes), is 174.8506 shares of common stock per $1,000 principal amount or approximately $5.72 per share, effective March 3, 2015....
INCLINE VILLAGE, Nev., March 3, 2015 /PRNewswire/ -- PDL BioPharma, Inc. (PDL or the Company) (NASDAQ: PDLI) today announced that the third of three shareholder lawsuits filed in the fall of 2014, was voluntarily dismissed without prejudice. On February 2, 2015, a securities lawsuit that was filed against the Company last September on behalf...
INCLINE VILLAGE, Nev., Feb. 26, 2015 /PRNewswire/ -- PDL BioPharma, Inc. (PDL or the Company) (NASDAQ: PDLI) today announced that the Company will hold its annual meeting of stockholders on Thursday, May 28, 2015, at 10:00 a.m. Pacific Time for all stockholders of record on April 2, 2015. The meeting will take place at the Hyatt Regency Hotel in In...
INCLINE VILLAGE, Nev., Feb. 23, 2015 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today reported financial results for the fourth quarter and year ended December 31, 2014. Total revenues in 2014 increased 27 percent to $581.2 million from $456.3 million in 2013. Revenues for the year ended December 31, 2014 included $487.5 milli...
INCLINE VILLAGE, Nev., Feb. 17, 2015 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that the Company will release its fourth quarter and full year 2014 financial results for the period ended December 31, 2014, on Monday, February 23, 2015, after market close. PDL's management will host a conference call and webcast that da...
Page: First Previous
...
...
Next Last
 
= add release to Briefcase